2nd Quarter - Report — SAM ACTION, INC. for SAM ACTION, INC. (2018)

Firm

SAM ACTION, INC.

Client

SAM ACTION, INC.

Income

—

Expenses

$10,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

H.R. 5952 - Commerce, Justice, Science, Financial Services and General Government, 2019: amendment related to marijuana, S. 3072 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019: amendment related to marijuana

Lobbyist	Covered position, as disclosed
MERVYN JONES New	—
GARTH VAN METER	Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; White House Office; Natl Institutes of Health (NIH); Justice, Dept of (DOJ); SENATE

Bills named: S. 3072 (115th), H.R. 5952 (115th)

Banking BAN

H.R. 6258, S. 3107 - Financial Services and General Government Appropriations Act, 2019, amendment related to marijuana; H.R. 6068 - Counter Terrorism and Illicit Finances Act, amendment related to marijuana

Lobbyist	Covered position, as disclosed
MERVYN JONES	—
GARTH VAN METER	Deputy Chief of Staff, US Rep. John Fleming (LA-4)

Contacted: Office of Natl Drug Control Policy (NDCP); White House Office; Food & Drug Administration (FDA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA)

Bills named: S. 3107 (115th), H.R. 6258 (115th), H.R. 6068 (115th)

Medical/Disease Research/Clinical Labs MED

H.R. 3391 - Medical Marijuana Research Act, H.R. 4825, S. 1803 - MEDS Act, S. 3024 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019: amendment related to marijuana, H.R. 5520 - VA Medicinal Cannabis Research Act

Lobbyist	Covered position, as disclosed
GARTH VAN METER	Deputy Chief of Staff, Rep. John Fleming (LA-4)

Contacted: Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); SENATE; White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: S. 1803 (115th), H.R. 3391 (115th), H.R. 5520 (115th), S. 3024 (115th), H.R. 4825 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.